Literature DB >> 27285320

Comment on: 'Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study'.

D Călugăru1, M Călugăru2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27285320      PMCID： PMC5107999          DOI： 10.1038/eye.2016.118

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Prevention of neovascular glaucoma.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Ophthalmology       Date:  2013-07       Impact factor: 12.079

2.  Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  J Ocul Pharmacol Ther       Date:  2014-10-14       Impact factor: 2.671

3.  Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naïve eyes with macular edema secondary to CRVO: prospective randomized study.

Authors:  J Chhablani; R Narayanan; A Mathai; M Tyagi
Journal:  Eye (Lond)       Date:  2016-04-01       Impact factor: 3.775

4.  Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.

Authors:  David L Epstein; Peep V Algvere; Gunvor von Wendt; Stefan Seregard; Anders Kvanta
Journal:  Ophthalmology       Date:  2012-08-17       Impact factor: 12.079

5.  Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).

Authors:  Sandeep Grover; Ravi K Murthy; Vikram S Brar; Kakarla V Chalam
Journal:  Am J Ophthalmol       Date:  2009-05-09       Impact factor: 5.258
  5 in total
  4 in total

1.  Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study.

Authors:  J Chhablani
Journal:  Eye (Lond)       Date:  2016-06-10       Impact factor: 3.775

Review 2.  Bevacizumab in the treatment of acute central/hemicentral retinal vein occlusions.

Authors:  Dan Călugăru; Mihai Călugăru; Ștefan Țălu
Journal:  Rom J Ophthalmol       Date:  2016 Jul-Sep

3.  Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management.

Authors:  Dan Călugăru; Mihai Călugăru; Ştefan Ţălu
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

4.  Eales disease in a young adult man Case report.

Authors:  Dan Călugăru; Mihai Călugăru; Chabi El Ghali
Journal:  Rom J Ophthalmol       Date:  2017 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.